Internal Medicine, Hematology & Oncology · La Jolla, CA
NPI
1730451089
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
10710 N Torrey Pines Rd
La Jolla, CA, 92037
Phone (858) 554-8788
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
157,129 services
Medicare patients, 2024
896
Average age 75
Drug cost, 2024
$2.3M
1,632 prescriptions
Company payments, 2025
$1,192
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sonia L Ali was code J9271 (injection, pembrolizumab, 1 mg), 10,000 times for 14 patients. In total Sonia L Ali billed 157,129 services in 133 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,000 | 14 | $44.43 | $444K |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,673 | 17 | $0.08 | $711 |
| J0897 Injection, denosumab, 1 mg | Office | 7,500 | 46 | $20.40 | $153K |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 7,200 | 12 | $0.25 | $1,836 |
| Q5116 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | Office | 6,243 | 19 | $11.65 | $73K |
| J9025 Injection, azacitidine, 1 mg | Office | 5,880 | 15 | $0.30 | $1,771 |
| J0185 Injection, aprepitant, 1 mg | Office | 4,030 | 15 | $1.34 | $5,411 |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 1,940 | 14 | $38.55 | $75K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,560 | 65 | $0.25 | $387 |
| J9395 Injection, fulvestrant, 25 mg | Office | 1,422 | 11 | $6.11 | $8,690 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,200 | 40 | $0.09 | $109 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 702 | 117 | $4.60 | $3,228 |
| 99214 Office E&M - Established | Office | 679 | 420 | $96.07 | $65K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 626 | 377 | $13.39 | $8,382 |
| 99215 Office E&M - Established | Office | 613 | 193 | $147.14 | $90K |
By year: 2022 $2.6M for 140,757 services; 2023 $2.1M for 112,694 services; 2024 $2.9M for 157,129 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 19 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Sonia L Ali prescribed most often to Medicare patients was Anastrozole, with 981 prescriptions and refills. In total Sonia L Ali wrote 1,632 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 981 | 2,791 | 335 | $23K |
| Tamoxifen Citrate Generic | 128 | 362 | 46 | $3,102 |
| Exemestane Generic | 82 | 208 | 34 | $17K |
| Ibrance Palbociclib | 59 | 59 | Under 11 | $923K |
| Letrozole Generic | 56 | 156 | 17 | $1,920 |
| Prochlorperazine Maleate Generic | 26 | 26 | 18 | $476 |
| Orserdu Elacestrant Hcl | 25 | 25 | Under 11 | $579K |
| Gabapentin Generic | 23 | 57 | Under 11 | $164 |
| Lorazepam Generic | 23 | 25 | Under 11 | $123 |
| Dexamethasone Generic | 19 | 19 | 11 | $447 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 18 | 20 | 14 | $211 |
| Ondansetron Hcl Generic | 14 | 14 | 14 | $112 |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $54.38 |
| Lynparza Olaparib | 13 | 13 | Under 11 | $192K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 12 | 12 | Under 11 | $223 |
Brand drugs: 151 claims; generic drugs: 1,481 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sonia L Ali $1,192 ($1,192 in general payments such as food, travel and fees) from 25 companies. The largest payer was Pfizer Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 10 | $144 |
| Astellas Pharma US Inc 4503.T | 4 | $126 |
| Abbvie Inc. ABBV | 5 | $123 |
| Karyopharm Therapeutics Inc. KPTI | 3 | $90.02 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $76.84 |
| Merck Sharp & Dohme LLC MRK | 3 | $75.51 |
| Genentech USA, Inc. ROG.SW | 2 | $55.87 |
| Daiichi Sankyo Inc. 4568.T | 2 | $55.06 |
| Stemline Therapeutics Inc. | 2 | $54.33 |
| GlaxoSmithKline, LLC. GSK | 1 | $34.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.